| Binding Specificity: |
AA 101-189 |
| Reactivity: |
Human |
| Host: |
Rabbit |
| Clonality: |
Polyclonal |
| Conjugate: |
This IFNA antibody is un-conjugated |
| Application: |
ELISA, immunofluorescence (cultured cells) (IF (cc)), immunofluorescence (paraffin-embedded sections) (IF (p)), immunohistochemistry (frozen sections) (IHC (fro)), immunohistochemistry (paraffin-embedded sections) (IHC (p)), western blotting (WB) |
| Specificity: |
This antibody will detect all 13 subtypes of Human IFN-Alpha |
| Predicted Reactivity: |
Human |
| Purification: |
Purified by protein A. |
| Immunogen: |
KLH conjugated synthetic peptide derived from human IFNA1. |
| Isotype: |
IgG |
| Format: |
Liquid |
| Concentration: |
1 μg/μL |
| Buffer: |
0.01 M TBS (pH7.4) with 1% BSA, 0.03% proclin300 and 50% glycerol. |
| Precaution of Use: |
This product contains a poisonous and hazardous substance, which should be handled by trained staff only. |
| Storage: |
- 20°C |
| Storage Comment: |
Store at - 20°C for one year. Avoid repeated freeze/thaw cycles. |
| Target: |
IFNA (Interferon alpha) |
| Alternative Name: |
IFN-alpha |
| Background: |
Interferon-alpha, also referred to as IFN-alpha, IFN-a, IFNA, is a type I interferon encompassing 13 subtypes: IFN-alpha 1, 2, 4, 5, 6, 7, 8, 10, 13, 14, 16, 17, and 21. These subtypes are predominantly synthesized by virus-infected cells upon detection of danger signals like viral DNA or RNA. Upon binding to its receptor, IFN-alpha triggers an antiviral response, with demonstrated anti-tumor effects as well. Plasmacytoid dendritic cells are significant contributors to the production of type I interferons. |
